Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N F Olivieri

Showing results (1-10 of 95) with videos related to

Pageof 10
Sort By:
Current Opinion in Hematology|March 1, 1996
Orally active iron chelators in the treatment of iron overloadN F Olivieri
Seminars in Hematology|January 1, 1996
Reactivation of fetal hemoglobin in patients with beta-thalassemiaN F Olivieri
Seminars in Hematology|February 24, 2001
Progression of iron overload in sickle cell diseaseN F Olivieri
Acta Haematologica|January 1, 1996
Long-term therapy with deferiproneN F Olivieri
The New England Journal of Medicine|July 8, 1999
The beta-thalassemiasN F Olivieri
Seminars in Perinatology|February 1, 1997
Fetal erythropoiesis and the diagnosis and treatment of hemoglobin disorders in the fetus and childN F Olivieri
Journal of Pediatric Hematology/Oncology|March 3, 1998
Hydroxyurea in children with sickle cell disease: impact on splenic function and compliance with therapyN F Olivieri, E P Vichinsky
Human Molecular Genetics|September 15, 1998
The therapeutic reactivation of fetal haemoglobinN F Olivieri, D J Weatherall
Annals of the New York Academy of Sciences|July 21, 1998
Long-term trials of deferiprone in Cooley's anemiaN F Olivieri, G M Brittenham
Blood|October 1, 1994
Rapid healing of chronic leg ulcers during arginine butyrate therapy in patients with sickle cell disease and thalassemiaG D Sher, N F Olivieri
Pageof 10

Showing results (1-10 of 95) with videos related to

Sort By:
Pageof 10
Current Opinion in Hematology|March 1, 1996
Orally active iron chelators in the treatment of iron overloadN F Olivieri
Seminars in Hematology|January 1, 1996
Reactivation of fetal hemoglobin in patients with beta-thalassemiaN F Olivieri
Seminars in Hematology|February 24, 2001
Progression of iron overload in sickle cell diseaseN F Olivieri
Acta Haematologica|January 1, 1996
Long-term therapy with deferiproneN F Olivieri
The New England Journal of Medicine|July 8, 1999
The beta-thalassemiasN F Olivieri
Seminars in Perinatology|February 1, 1997
Fetal erythropoiesis and the diagnosis and treatment of hemoglobin disorders in the fetus and childN F Olivieri
Journal of Pediatric Hematology/Oncology|March 3, 1998
Hydroxyurea in children with sickle cell disease: impact on splenic function and compliance with therapyN F Olivieri, E P Vichinsky
Human Molecular Genetics|September 15, 1998
The therapeutic reactivation of fetal haemoglobinN F Olivieri, D J Weatherall
Annals of the New York Academy of Sciences|July 21, 1998
Long-term trials of deferiprone in Cooley's anemiaN F Olivieri, G M Brittenham
Blood|October 1, 1994
Rapid healing of chronic leg ulcers during arginine butyrate therapy in patients with sickle cell disease and thalassemiaG D Sher, N F Olivieri
Pageof 10